Journal
FEBS LETTERS
Volume 594, Issue 24, Pages 4201-4232Publisher
WILEY
DOI: 10.1002/1873-3468.14017
Keywords
angiogenesis; cancer; cancer metabolism; G protein‐ coupled receptors; GTPases; immune therapy; inflammation; metastasis; precision medicine; signal transduction
Funding
- NCI NIH HHS [1R33CA225291, R33 CA225291] Funding Source: Medline
Ask authors/readers for more resources
G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play central roles in a diverse array of cellular processes. As such, dysregulation of GPCRs and their coupled heterotrimeric G proteins can dramatically alter the signalling landscape and functional state of a cell. Consistent with their fundamental physiological functions, GPCRs and their effector heterotrimeric G proteins are implicated in some of the most prevalent human diseases, including a complex disease such as cancer that causes significant morbidity and mortality worldwide. GPCR/G protein-mediated signalling impacts oncogenesis at multiple levels by regulating tumour angiogenesis, immune evasion, metastasis, and drug resistance. Here, we summarize the growing body of research on GPCRs and their effector heterotrimeric G proteins as drivers of cancer initiation and progression, and as emerging antitumoural therapeutic targets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available